Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

Medical - Care Facilities

Healthcare
$10.85 +1.33%

+$0.10 today

Market cap
$2.37B
Beta
1.93
P/E (TTM)
6.3
EPS (TTM)
$1.22
52W Low $3.73High $10.32

Volume 2.12M

Average 1.52M

AVAH Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Aveanna Healthcare Holdings Inc.NASDAQ: AVAH

Research & Development · Q3 FY2026 · quarter ended Oct 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterOct 2026
$0— QoQ
Last fiscal yearJan 2026
$0— YoY
LTMOct 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How AVAH compares with its peers on the latest reported figures

  • AVAH's LTM Oct 2026 research & development of $0 is the 2nd highest of the 7 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for AVAH, versus a peer median of 0.0%.
AVAH Competitors Peer median
Research & Development for AVAH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VMDViemed Healthcare, Inc.LTM Mar 2026$2.8M -10.1%+3.8%1.0%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$0 ——0.0%
EHCEncompass Health CorporationLTM Jun 2026$0 ——0.0%
CHEChemed CorporationLTM Jun 2026$0 ——0.0%
OPCHOption Care Health, Inc.LTM Sep 2026$0 ——0.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$0 ——0.0%
PNTGThe Pennant Group, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding AVAH) $0-10.1%+3.8%0.0%

Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.68B1.79B1.9B2.02B2.43B
Cost of Revenue1.14B1.23B1.3B1.39B1.63B
Gross Profit542.4M553.23M595.43M635.54M805.15M
Gross Margin32.3%30.9%31.4%31.4%33.1%
Research & Development00000
Selling, General & Admin419.64M483.95M464.74M470.47M526.74M
Operating Expenses578.52M1.2B587.36M495.76M539.77M
Depreciation & Amortization35.39M38.82M30.1M31.16M28.22M
EBITDA(17.96M)(525.06M)39.17M187.38M279.02M
EBITDA Margin-1.1%-29.4%2.1%9.3%11.5%
Operating Income(36.11M)(642.28M)8.07M139.79M265.38M
Operating Margin-2.2%-35.9%0.4%6.9%10.9%
Interest Income253K679K327K498K2.83M
Interest Expense68.93M107.72M153.25M156.6M140.09M
Other Income / Expenses(77.47M)(21.54M)(147.07M)(134.72M)(158.43M)
Income Before Tax(113.58M)(663.81M)(139M)5.07M106.95M
Pre-Tax Margin-6.8%-37.1%-7.3%0.3%4.4%
Income Tax Expense3.47M(1.78M)(4.47M)16M(118.09M)
Net Income(117.04M)(662.03M)(134.52M)(10.93M)225.03M
Net Margin-7.0%-37.0%-7.1%-0.5%9.2%
EPS (Basic)(0.63)(3.57)(0.71)(0.06)1.10
EPS (Diluted)(0.63)(3.57)(0.71)(0.06)1.05
Weighted Avg Shares184.73M185.55M189.96M192.89M203.53M
Weighted Avg Shares (Diluted)184.73M185.55M189.96M192.89M214.98M

Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

Intrinsic Alpha fair value

Locked

Current Price

$10.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.